About Ruby Nanomed
Ruby Nanomed is a company based in Braga (Portugal) founded in 2018. Ruby Nanomed offers products and services including RUBYchip. Ruby Nanomed operates in a competitive market with competitors including Scholar Rock, Lightpoint Medical, Nodexus, Chromition and Delee, among others.
- Headquarter Braga, Portugal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.57 M (USD), Grant
Aug 01, 2022
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ruby Nanomed
Ruby Nanomed offers a comprehensive portfolio of products and services, including RUBYchip.
Non-invasive device for real-time cancer progression monitoring.
Funding Insights of Ruby Nanomed
Investors in Ruby Nanomed
Ruby Nanomed has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Ruby Nanomed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ruby Nanomed
Investment portfolio details for Ruby Nanomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ruby Nanomed
Detailed financials for Ruby Nanomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ruby Nanomed Comparisons
Peer comparison for Ruby Nanomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ruby Nanomed
Ruby Nanomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, Lightpoint Medical, Nodexus, Chromition and Delee, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
Intraoperative imaging devices for real-time cancer detection are developed.
|
|
| Locked | Locked | Locked |
Microfluidic systems are developed for detecting metastatic cancer.
|
|
| Locked | Locked | Locked |
Nanoparticle-based solutions for displays and lighting are provided.
|
|
| Locked | Locked | Locked |
Provider of a medical device for detecting and monitoring cancer
|
|
| Locked | Locked | Locked |
Pre-screening cancer tests are offered via nanoscale cytology platform.
|
Detailed competitors of Ruby Nanomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ruby Nanomed
Complete news archive for Ruby Nanomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ruby Nanomed
Ruby Nanomed was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Ruby Nanomed is headquartered in Braga, Portugal.
Ruby Nanomed was founded in 2018 in Braga, Portugal, within the biotechnology sector focused on oncology. Operations center on the development of a microfluidic device known as RUBYchipTM, which isolates various types of circulating tumor cells from unprocessed whole blood. This technology is applied in non-invasive monitoring of cancer progression and in guiding treatment options for patients.
Ruby Nanomed's top competitors include Scholar Rock, Lightpoint Medical and Nodexus.
Ruby Nanomed offers RUBYchip.
Ruby Nanomed has 2 investors. Key investors include European Union, and EIC Fund.